Opportunity Information: Apply for PA 13 352
Apply for PA 13 352
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Translational Research to Improve Diabetes and Obesity Outcomes (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Sep 12, 2013 and posted on Sep 12, 2013.
- Applicants must submit their applications by Jan 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Translational Research to Improve Diabetes and Obesity Outcomes (R01)" (Funding Opportunity Number PA-13-352) is an NIH Research Project Grant announcement designed to move proven diabetes and obesity interventions closer to real-world use. The focus is on taking strategies that already have evidence of efficacy and adapting them so they work better in practical settings, remain sustainable over time, and are cost efficient. In other words, the FOA is less about discovering entirely new biological mechanisms and more about improving how effective prevention and treatment approaches can be delivered, maintained, and scaled in everyday clinical or community environments.
The FOA encourages research aimed at several major outcome areas: preventing or reversing obesity, preventing type 2 diabetes, improving care for people with type 1 diabetes and type 2 diabetes, and preventing or delaying complications associated with these conditions. A key theme is implementation potential beyond academia. NIH is signaling that proposed interventions should be built with dissemination in mind, meaning they should be feasible in routine clinical practice, public health programs, and community settings, especially those serving populations at elevated risk. Projects are expected to test adaptations that make interventions workable under real constraints such as limited staffing, time, infrastructure, and budgets, while still preserving meaningful health benefits.
This opportunity uses the R01 mechanism, which supports a defined research project and typically allows investigators to propose a multi-year plan with clear aims, study design, and measurable outcomes. The activity category is listed under Food and Nutrition/Health, and it falls under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), reflecting NIH's interest in practical translational work that can improve population health related to diabetes and obesity.
Eligibility is broad and includes many types of U.S.-based organizations across the public, private, and nonprofit sectors. Eligible applicants include state, county, city or township, and special district governments; public and private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; small businesses; and for-profit organizations other than small businesses. Nonprofits are eligible whether or not they have 501(c)(3) status (with the caveat noted in the listing), and multiple categories of tribal entities are included, such as federally recognized tribal governments and other Native American tribal organizations. The FOA also explicitly includes a range of mission-driven and capacity-building institutions and organizations as eligible, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and certain eligible federal agencies. At the same time, the announcement makes clear that non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed, keeping the work fully domestic in scope.
Administrative details show that this is a discretionary grant program administered by the National Institutes of Health, with no cost sharing or matching requirement. The FOA was posted and created on September 12, 2013, with an original and current closing date of January 7, 2017, and an archive date of February 7, 2017, meaning the specific announcement is no longer open for application in its listed form. The full archived announcement was hosted at the NIH grants page (link provided in the source), and NIH’s Office of Extramural Research (OER) webmaster contact was provided for access or technical issues related to the posting.
Overall, the heart of PA-13-352 is practical translation: testing adaptations of interventions that already work so they can work at scale, at reasonable cost, and in the real settings where most people receive care or support. The strongest-fit projects under this kind of FOA are typically those that can demonstrate not only health impact (for obesity, diabetes prevention, diabetes management, or complication reduction), but also feasibility, sustainability, and a clear pathway for broader adoption in clinics and communities.
FAQs: Translational Research to Improve Diabetes and Obesity Outcomes (R01) (PA-13-352)
What is the "Translational Research to Improve Diabetes and Obesity Outcomes (R01)" funding opportunity?
It is an NIH Research Project Grant (R01) funding opportunity (Funding Opportunity Number PA-13-352) focused on moving proven diabetes and obesity interventions closer to real-world use. The emphasis is on adapting interventions that already have evidence of efficacy so they work well in practical settings, can be sustained over time, and remain cost efficient.
What is the main goal of PA-13-352?
The main goal is practical translation: testing and refining how evidence-based prevention and treatment approaches for diabetes and obesity can be delivered, maintained, and scaled in everyday clinical, public health, and community environments.
Is this opportunity about discovering new biological mechanisms?
No. The description emphasizes that the FOA is less about discovering entirely new biological mechanisms and more about improving how proven approaches are delivered, maintained, and disseminated in real-world settings.
What kinds of interventions are a fit for this FOA?
Interventions that already have evidence of efficacy and are ready to be adapted for routine use. Projects are expected to evaluate adaptations that improve feasibility under real constraints while preserving meaningful health benefits.
What outcome areas does the FOA encourage?
The FOA encourages research aimed at: preventing or reversing obesity; preventing type 2 diabetes; improving care for people with type 1 diabetes and type 2 diabetes; and preventing or delaying complications associated with diabetes and obesity.
What does NIH mean by "real-world use" in this announcement?
Real-world use refers to interventions that can function in routine clinical practice, public health programs, and community settings, including environments with limited staffing, time, infrastructure, and budgets.
What does "built with dissemination in mind" mean here?
It means proposed interventions should be designed for adoption beyond academic settings. The research should support feasibility and broader implementation in clinics and communities, especially those serving populations at elevated risk.
What types of constraints should projects account for?
The FOA highlights practical constraints such as limited staffing, limited time, limited infrastructure, and limited budgets. Adaptations should help interventions work under these constraints while maintaining meaningful health outcomes.
What grant mechanism is used?
This opportunity uses the NIH R01 mechanism, which supports a defined research project. It typically allows a multi-year plan with clear aims, a study design, and measurable outcomes.
What activity category and CFDA number are associated with this FOA?
The activity category is listed under Food and Nutrition/Health. The CFDA listing provided is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
Who is eligible to apply?
Eligibility is broad for U.S.-based organizations and includes state, county, city or township, and special district governments; public and private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; small businesses; and for-profit organizations other than small businesses.
Are nonprofit organizations eligible?
Yes. Nonprofits are eligible whether or not they have 501(c)(3) status, with the caveat noted in the listing.
Are tribal entities eligible?
Yes. The FOA includes federally recognized tribal governments and other Native American tribal organizations among eligible applicants.
Are minority-serving institutions and community organizations eligible?
Yes. The FOA explicitly includes a range of mission-driven and capacity-building institutions and organizations, including HBCUs, Hispanic-serving institutions, TCCUs, Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, and faith-based or community-based organizations. Certain eligible federal agencies are also included.
Can non-U.S. organizations apply?
No. The announcement states that non-U.S. entities are not eligible to apply.
Can a U.S. organization include a non-U.S. component or foreign component?
No. The FOA states that non-U.S. components of U.S. organizations are not eligible and that foreign components (as defined by NIH policy) are not allowed.
Is cost sharing or matching required?
No. The administrative details specify that there is no cost sharing or matching requirement.
What type of grant program is this?
It is a discretionary grant program administered by the National Institutes of Health (NIH).
When was this FOA posted, and is it still open?
The FOA was posted and created on September 12, 2013. Its listed closing date was January 7, 2017, and the archive date was February 7, 2017. Based on those dates, the specific announcement is no longer open for application in its listed form.
Where was the official announcement hosted?
The full archived announcement was hosted on the NIH grants page (link provided in the source description).
Who was listed as a contact for technical issues related to the posting?
The NIH Office of Extramural Research (OER) webmaster contact was provided for access or technical issues related to the posting.
What would a strong-fit project typically demonstrate under this FOA?
A strong-fit project would typically demonstrate health impact (obesity outcomes, diabetes prevention, diabetes management, or complication reduction) along with feasibility, sustainability, cost efficiency, and a credible pathway for broader adoption in clinics and community settings.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: R40 Maternal and Child Health Policy Analysis Program
Previous opportunity: R40 Maternal and Child Health Secondary Data Analysis Studies (MCH SDAS)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 352
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 352) also looked into and applied for these:
| Funding Opportunity |
|---|
| Harvesting the Neuroimaging Cornucopia for Pancreatic Islet Imaging Reagents for Diabetes Research (DP3) Apply for RFA DK 13 024 Funding Number: RFA DK 13 024 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| Human Islet Research Network Coordinating Center (U01) Apply for RFA DK 13 013 Funding Number: RFA DK 13 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Human Islet Research Network Bioinformatics Center (U01) Apply for RFA DK 13 014 Funding Number: RFA DK 13 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $333,000 |
| Consortium on Targeting And Regeneration (CTAR) HIRN (UC4) Apply for RFA DK 13 015 Funding Number: RFA DK 13 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Consortium on Human Islet Biomimetics (CHIB) HIRN (UC4) Apply for RFA DK 13 016 Funding Number: RFA DK 13 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,200,000 |
| Consortium on Modeling Autoimmune Interactions (CMAI) HIRN (UC4) Apply for RFA DK 13 017 Funding Number: RFA DK 13 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Consortium on Beta cell Death and Survival (CBDS) HIRN (UC4) Apply for RFA DK 13 018 Funding Number: RFA DK 13 018 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18) Apply for PAR 13 365 Funding Number: PAR 13 365 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18) Apply for PAR 13 366 Funding Number: PAR 13 366 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34) Apply for PAR 13 367 Funding Number: PAR 13 367 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological Diseases (U01) Apply for RFA DK 13 026 Funding Number: RFA DK 13 026 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Biomarkers for Diabetes Complications Non Invasive Measures in the Eye (DP3) Apply for RFA DK 13 027 Funding Number: RFA DK 13 027 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Limited Competition for the Data Coordinating Center for Type I Diabetes TrialNet (UC4) Apply for RFA DK 13 508 Funding Number: RFA DK 13 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 13 020 Funding Number: RFA DK 13 020 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDKs Mission (Revisions) (R01) Apply for PAR 14 006 Funding Number: PAR 14 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $75,000 |
| Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas (SBIR) (R43/R44) Apply for RFA DK 13 028 Funding Number: RFA DK 13 028 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to NIDDK (STTR (R41/R42)) Apply for PA 14 054 Funding Number: PA 14 054 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (SBIR (R43/R44)) Apply for PA 14 055 Funding Number: PA 14 055 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Business Technology Transfer Research (STTR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) STTR (R41/R42) Apply for PA 14 059 Funding Number: PA 14 059 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Business Innovation Research (SBIR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) (SBIR (R43/R44)) Apply for PA 14 058 Funding Number: PA 14 058 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 352", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
